Log In
BCIQ
Print this Print this
 

XL499

  Manage Alerts
Collapse Summary General Information
Company Exelixis Inc.
DescriptionSelective inhibitor of phosphoinositide 3-kinase (PI3K) delta
Molecular Target Phosphoinositide 3-kinase (PI3K) delta
Mechanism of ActionPhosphoinositide 3-kinase (PI3K) delta inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

$12.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/02/2012

Undisclosed

$12.0M

Undisclosed

Get a free BioCentury trial today